ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions

Arnaud Bourdin, Leif Bjermer, Christopher Brightling, Guy G. Brusselle, Pascal Chanez, Kian Fan Chung, Adnan Custovic, Zuzana Diamant, Sarah Diver, Ratko Djukanovic, Dominique Hamerlijnck, I. Horváth, Sebastian L. Johnston, Frank Kanniess, Nikos Papadopoulos, Alberto Papi, Richard J. Russell, Dermot Ryan, Konstantinos Samitas, Thomy ToniaEleftherios Zervas, Mina Gaga

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Despite the use of effective medications to control asthma, severe exacerbations in asthma are still a major health risk and require urgent action on the part of the patient and physician to prevent serious outcomes such as hospitalisation or death. Moreover, severe exacerbations are associated with substantial healthcare costs and psychological burden, including anxiety and fear for patients and their families. The European Academy of Allergy and Clinical Immunology (EAACI) and the European Respiratory Society (ERS) set up a task force to search for a clear definition of severe exacerbations, and to also define research questions and priorities. The statement includes comments from patients who were members of the task force.

Original languageEnglish
JournalThe European respiratory journal
Volume54
Issue number3
DOIs
Publication statusPublished - Sep 1 2019

Fingerprint

Allergy and Immunology
Asthma
Advisory Committees
Research
Health Care Costs
Fear
Hospitalization
Anxiety
Psychology
Physicians
Health

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

ERS/EAACI statement on severe exacerbations in asthma in adults : facts, priorities and key research questions. / Bourdin, Arnaud; Bjermer, Leif; Brightling, Christopher; Brusselle, Guy G.; Chanez, Pascal; Chung, Kian Fan; Custovic, Adnan; Diamant, Zuzana; Diver, Sarah; Djukanovic, Ratko; Hamerlijnck, Dominique; Horváth, I.; Johnston, Sebastian L.; Kanniess, Frank; Papadopoulos, Nikos; Papi, Alberto; Russell, Richard J.; Ryan, Dermot; Samitas, Konstantinos; Tonia, Thomy; Zervas, Eleftherios; Gaga, Mina.

In: The European respiratory journal, Vol. 54, No. 3, 01.09.2019.

Research output: Contribution to journalArticle

Bourdin, A, Bjermer, L, Brightling, C, Brusselle, GG, Chanez, P, Chung, KF, Custovic, A, Diamant, Z, Diver, S, Djukanovic, R, Hamerlijnck, D, Horváth, I, Johnston, SL, Kanniess, F, Papadopoulos, N, Papi, A, Russell, RJ, Ryan, D, Samitas, K, Tonia, T, Zervas, E & Gaga, M 2019, 'ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions', The European respiratory journal, vol. 54, no. 3. https://doi.org/10.1183/13993003.00900-2019
Bourdin, Arnaud ; Bjermer, Leif ; Brightling, Christopher ; Brusselle, Guy G. ; Chanez, Pascal ; Chung, Kian Fan ; Custovic, Adnan ; Diamant, Zuzana ; Diver, Sarah ; Djukanovic, Ratko ; Hamerlijnck, Dominique ; Horváth, I. ; Johnston, Sebastian L. ; Kanniess, Frank ; Papadopoulos, Nikos ; Papi, Alberto ; Russell, Richard J. ; Ryan, Dermot ; Samitas, Konstantinos ; Tonia, Thomy ; Zervas, Eleftherios ; Gaga, Mina. / ERS/EAACI statement on severe exacerbations in asthma in adults : facts, priorities and key research questions. In: The European respiratory journal. 2019 ; Vol. 54, No. 3.
@article{97a938c444a74032b030e816631f38ff,
title = "ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions",
abstract = "Despite the use of effective medications to control asthma, severe exacerbations in asthma are still a major health risk and require urgent action on the part of the patient and physician to prevent serious outcomes such as hospitalisation or death. Moreover, severe exacerbations are associated with substantial healthcare costs and psychological burden, including anxiety and fear for patients and their families. The European Academy of Allergy and Clinical Immunology (EAACI) and the European Respiratory Society (ERS) set up a task force to search for a clear definition of severe exacerbations, and to also define research questions and priorities. The statement includes comments from patients who were members of the task force.",
author = "Arnaud Bourdin and Leif Bjermer and Christopher Brightling and Brusselle, {Guy G.} and Pascal Chanez and Chung, {Kian Fan} and Adnan Custovic and Zuzana Diamant and Sarah Diver and Ratko Djukanovic and Dominique Hamerlijnck and I. Horv{\'a}th and Johnston, {Sebastian L.} and Frank Kanniess and Nikos Papadopoulos and Alberto Papi and Russell, {Richard J.} and Dermot Ryan and Konstantinos Samitas and Thomy Tonia and Eleftherios Zervas and Mina Gaga",
year = "2019",
month = "9",
day = "1",
doi = "10.1183/13993003.00900-2019",
language = "English",
volume = "54",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "3",

}

TY - JOUR

T1 - ERS/EAACI statement on severe exacerbations in asthma in adults

T2 - facts, priorities and key research questions

AU - Bourdin, Arnaud

AU - Bjermer, Leif

AU - Brightling, Christopher

AU - Brusselle, Guy G.

AU - Chanez, Pascal

AU - Chung, Kian Fan

AU - Custovic, Adnan

AU - Diamant, Zuzana

AU - Diver, Sarah

AU - Djukanovic, Ratko

AU - Hamerlijnck, Dominique

AU - Horváth, I.

AU - Johnston, Sebastian L.

AU - Kanniess, Frank

AU - Papadopoulos, Nikos

AU - Papi, Alberto

AU - Russell, Richard J.

AU - Ryan, Dermot

AU - Samitas, Konstantinos

AU - Tonia, Thomy

AU - Zervas, Eleftherios

AU - Gaga, Mina

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Despite the use of effective medications to control asthma, severe exacerbations in asthma are still a major health risk and require urgent action on the part of the patient and physician to prevent serious outcomes such as hospitalisation or death. Moreover, severe exacerbations are associated with substantial healthcare costs and psychological burden, including anxiety and fear for patients and their families. The European Academy of Allergy and Clinical Immunology (EAACI) and the European Respiratory Society (ERS) set up a task force to search for a clear definition of severe exacerbations, and to also define research questions and priorities. The statement includes comments from patients who were members of the task force.

AB - Despite the use of effective medications to control asthma, severe exacerbations in asthma are still a major health risk and require urgent action on the part of the patient and physician to prevent serious outcomes such as hospitalisation or death. Moreover, severe exacerbations are associated with substantial healthcare costs and psychological burden, including anxiety and fear for patients and their families. The European Academy of Allergy and Clinical Immunology (EAACI) and the European Respiratory Society (ERS) set up a task force to search for a clear definition of severe exacerbations, and to also define research questions and priorities. The statement includes comments from patients who were members of the task force.

UR - http://www.scopus.com/inward/record.url?scp=85072747678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072747678&partnerID=8YFLogxK

U2 - 10.1183/13993003.00900-2019

DO - 10.1183/13993003.00900-2019

M3 - Article

C2 - 31467120

AN - SCOPUS:85072747678

VL - 54

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 3

ER -